Monopar Therapeutics (MNPR) Other Working Capital Changes (2017 - 2025)
Monopar Therapeutics (MNPR) reported Other Working Capital Changes of -$709403.0 for Q4 2025, down 2484.39% on a YoY basis from $29752.0 in Q4 2024, and down 761.5% sequentially from $107242.0 in Q3 2025.
Monopar Therapeutics (MNPR) Other Working Capital Changes (2017 - 2025) Analysis & Trends
Monopar Therapeutics (MNPR) has 9 years of Other Working Capital Changes data on file, last reported at -$709403.0 in Q4 2025.
- For the quarter ending Q4 2025, Other Working Capital Changes fell 2484.39% year-over-year to -$709403.0; the trailing twelve-month figure through Dec 2025 stood at -$15404.0 (down 220.57% YoY), and the FY2025 full-year result was -$15404.0, down 220.57% from the prior year.
- Other Working Capital Changes retreated to -$709403.0 in Q4 2025, from $107242.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $621543.0 in Q1 2025 to a low of -$709403.0 in Q4 2025.
- A 5-year average of -$12008.6 and a median of -$8273.5 in 2022 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 3720.59% in 2025, while the deepest fall reached 2484.39% in 2025.
- Tracing MNPR's Other Working Capital Changes over 5 years: stood at -$42087.0 in 2021, then surged by 76.86% to -$9738.0 in 2022, then jumped by 30.08% to -$6809.0 in 2023, then surged by 536.95% to $29752.0 in 2024, then tumbled by 2484.39% to -$709403.0 in 2025.
- Business Quant data shows MNPR's Other Working Capital Changes at -$709403.0 in Q4 2025, $107242.0 in Q3 2025, and -$34786.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Monopar Therapeutics | 707.36 Mn | 645.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -709,403.00 |
| Dec 31, 2025 | -709,403.00 |
| Dec 31, 2025 | -709,403.00 |
| Sep 30, 2025 | 107,242.00 |
| Sep 30, 2025 | 107,242.00 |
| Sep 30, 2025 | 107,242.00 |
| Jun 30, 2025 | -34,786.00 |
| Jun 30, 2025 | -34,786.00 |
| Jun 30, 2025 | -34,786.00 |
| Mar 31, 2025 | 621,543.00 |
| Mar 31, 2025 | 621,543.00 |
| Mar 31, 2025 | 621,543.00 |
| Dec 31, 2024 | 29,752.00 |
| Dec 31, 2024 | 29,752.00 |
| Dec 31, 2024 | 29,752.00 |
| Sep 30, 2024 | -2,962.00 |
| Sep 30, 2024 | -2,962.00 |
| Sep 30, 2024 | -2,962.00 |
| Jun 30, 2024 | -49,871.00 |
| Jun 30, 2024 | -49,871.00 |